Skoie IM, Skogås JG, Langø T, Myhr KM, Myhre PL, Goll R, Fretland SØ, Helland Å(2023) New centres to carry out more clinical trials in Norway Tidsskr Nor Laegeforen, 143(2) DOI 10.4045/tidsskr.22.0722, PubMed 36718905
Børø S, Thoresen S, Helland Å(2022) Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 - 2020 - A population-based registry study from Norway Front Oncol, 12, 1017902 DOI 10.3389/fonc.2022.1017902, PubMed 36523970
Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM(2022) A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT) Front Oncol, 12, 1031232 DOI 10.3389/fonc.2022.1031232, PubMed 36439452